Allogene Therapeutics, Inc.ALLONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-200.99M
↓ 25% below average
Average (7y)
$-161.16M
Historical baseline
Range
High:$0.00
Low:$-239.25M
Volatility
-148.5%
Relatively stable
| Period | Value | Change |
|---|---|---|
| 2024 | $-200.99M | +16.0% |
| 2023 | $-239.25M | -6.0% |
| 2022 | $-225.71M | -9.4% |
| 2021 | $-206.26M | -13.9% |
| 2020 | $-181.05M | +3.8% |
| 2019 | $-188.14M | -292.9% |
| 2018 | $-47.89M | - |
| 2017 | $0.00 | - |